We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $336.40, moving +1.91% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.19%. Meanwhile, the Dow gained 0.66%, and the Nasdaq, a tech-heavy index, lost 0.03%.
The largest U.S. health insurer's shares have seen a decrease of 1.01% over the last month, not keeping up with the Medical sector's gain of 0.17% and the S&P 500's gain of 0.54%.
Market participants will be closely following the financial results of UnitedHealth Group in its upcoming release. The company plans to announce its earnings on January 27, 2026. The company is predicted to post an EPS of $2.09, indicating a 69.31% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $113.64 billion, indicating a 12.73% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $16.3 per share and a revenue of $448.03 billion, demonstrating changes of -41.07% and 0%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. UnitedHealth Group currently has a Zacks Rank of #3 (Hold).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 18.75. This denotes a premium relative to the industry average Forward P/E of 14.01.
It is also worth noting that UNH currently has a PEG ratio of 1.99. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 0.97 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 234, placing it within the bottom 5% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
UnitedHealth Group (UNH - Free Report) closed the most recent trading day at $336.40, moving +1.91% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.19%. Meanwhile, the Dow gained 0.66%, and the Nasdaq, a tech-heavy index, lost 0.03%.
The largest U.S. health insurer's shares have seen a decrease of 1.01% over the last month, not keeping up with the Medical sector's gain of 0.17% and the S&P 500's gain of 0.54%.
Market participants will be closely following the financial results of UnitedHealth Group in its upcoming release. The company plans to announce its earnings on January 27, 2026. The company is predicted to post an EPS of $2.09, indicating a 69.31% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $113.64 billion, indicating a 12.73% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $16.3 per share and a revenue of $448.03 billion, demonstrating changes of -41.07% and 0%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for UnitedHealth Group. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. UnitedHealth Group currently has a Zacks Rank of #3 (Hold).
In the context of valuation, UnitedHealth Group is at present trading with a Forward P/E ratio of 18.75. This denotes a premium relative to the industry average Forward P/E of 14.01.
It is also worth noting that UNH currently has a PEG ratio of 1.99. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. UNH's industry had an average PEG ratio of 0.97 as of yesterday's close.
The Medical - HMOs industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 234, placing it within the bottom 5% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.